
Semaglutide and similar prescription drugs are mentioned as pharmaceuticals that capitalize on the glp1 pathway. These drugs, used for treating diabetes, can lead to significant weight loss and appetite reduction but require a prescription.

"Semaglutide and similar GLP-1 drugs are mentioned in the context of prescription medications for diabetes that also aid in weight loss by influencing the GLP-1 pathway. While impactful, they are prescription-only."




